Mineralocorticoids: Difference between revisions

*[[Mineralocorticoid receptor]] (MR) in epithelial cells is activated by the <scene name='89/896192/Cv/1'>mineralocorticoid hormone aldosterone</scene> promoting renal sodium retention and potassium excretion. It is [[Nuclear receptors|nuclear receptor]]. In non epithelial cells MR is activated by cortisol<ref>PMID:15199296</ref>.  MR is exposed to many steroids including cortisol, cortisone and progesterone, however, aldosterone and deoxycorticosterone are its physiological ligands. MR mutations are the principal cause of renal pseudohypoaldosteronism<ref>PMID:16972228</ref>. MR mutation S810L causes early-onset hypertension<ref>PMID:10884226</ref>. Inhibition of cardia MR prevents doxorubicin-induced cardiotoxicity<ref>PMID:28430882</ref>. MR is an important proadipogenic transcription factor that may mediate aldosterone and glucocorticoid effects on adipose tissue development and hence on obesity and development of metabolic syndrome<ref>PMID:17384139</ref>. The MR ligand aldosterone binds in a <scene name='78/781019/Cv/6'>fully enclosed pocket, contacting residues with six α-helices and a β-turn</scene> ({{Template:ColorKey_Helix}},{{Template:ColorKey_Strand}},{{Template:ColorKey_Loop}},{{Template:ColorKey_Turn}}). <scene name='78/781019/Cv/7'>It forms hydrogen bonds with 4 MR residues</scene><ref>PMID:15967794</ref>. <scene name='78/781019/Cv/8'>Whole binding site</scene>. Water molecules are shown as red spheres.